10. Kokubo T, Takadama H. How useful is SBF in predictingin vivo bone bioactivity? Biomaterials, 2006, 27(15): 2907-2915.
[2]
14. Kameda T, Mano H, Yamada Y,et al. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun, 1998, 245(2): 419-422.
[3]
11. Athanasiou KA, Zhu C, Lanctot DR,et al. Fundamentals of biomechanics in tissue engineering of bone. Tissue Eng, 2000, 6(4): 361-381.
2. Peltier LF, Bickel EY, Lillo R,et al. The use of plaster of paris to fill defects in bone. Ann Surg, 1957, 146(1): 61-69.
[7]
3. Robinson D, Alk D, Sanbank J,et al. Inflammatory reactions associated with a calcium sulfate bone substitute. Ann Transplant, 1999, 4(3-4): 91-97.
[8]
4. Chen J, Gao J, Yin H,et al. Size-controlled preparation of alpha-calcium sulphate hemihydrate starting from calcium sulphate dihydrate in the presence of modifiers and the dissolution rate in simulated body fluid. Mater Sci Eng C Mater Biol Appl, 2013, 33(6): 3256-3262.
[9]
5. Cai Z, Zhang T, Di L,et al. Morphological and histological analysis on thein vivo degradation of poly (propylene fumarate)/(calcium sulfate/β-tricalcium phosphate). Biomed Microdevices, 2011, 13(4): 623-631.
[10]
6. Vorndran E, Geffers M, Ewald A,et al. Ready-to-use injectable calcium phosphate bone cement paste as drug carrier. Acta Biomater, 2013, 9(12): 9558-9567.
9. Chang KC, Chang CC, Chen WT,et al. Development of calcium phosphate/sulfate biphasic cement for vital pulp therapy. Dent Mater, 2014, 30(12): e362-e370.
[14]
12. Yaszemski MJ, Payne RG, Hayes WC,et al. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials, 1996, 17(2): 175-185.